Invention Grant
- Patent Title: Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
-
Application No.: US15867825Application Date: 2018-01-11
-
Publication No.: US10369140B2Publication Date: 2019-08-06
- Inventor: Huji Turdi , Jon J. Hangeland , R. Michael Lawrence , Saleem Ahmad , Wei Meng , Robert Paul Brigance , Pratik Devasthale , Guohua Zhao
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Jing G. Sun
- Main IPC: C07F9/40
- IPC: C07F9/40 ; C07F9/59 ; A61K45/06 ; C07F9/535 ; A61K31/438 ; A61K31/675 ; C07D211/86 ; C07D211/90 ; C07D221/20 ; C07D401/04 ; C07D401/10 ; C07D401/12 ; C07D401/14 ; C07D405/14 ; C07D407/14 ; C07D413/04 ; C07D413/12 ; C07D413/14 ; C07D417/04 ; C07D417/14 ; A61K31/4418 ; A61K31/4439 ; A61K31/5377
Abstract:
The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.
Public/Granted literature
- US20180133198A1 ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS Public/Granted day:2018-05-17
Information query
